Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

CCCC C4 Therapeutics Inc

4,37

0,32 (7,90%)

22 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

C4 Therapeutics (NASDAQ:CCCC)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more C4 Therapeutics Charts.

C4 Therapeutics (NASDAQ:CCCC)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more C4 Therapeutics Charts.

News C4 Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 11 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 11 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 10 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
Montag 10 Juni 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Mittwoch 8 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Montag 29 April 2024 (2 Monate vor) • GlobeNewswire Inc.

C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum
Dienstag 9 April 2024 (2 Monate vor) • GlobeNewswire Inc.

C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
Montag 8 April 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 9 März 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere C4 Therapeutics Inc News-Artikel

Credit Agricole CIB Fina...

Ambac Financial

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen